Enhanced Blister Pack for Medicinal Products with Improved Safety and Efficiency

An improved blister pack design that enhances product safety, ease of use, and production efficiency, while providing controlled release of medicinal substances over a predetermined period.

The original blister pack design had limitations in terms of sharp edges, product removal difficulties, and limited storage capacity. The new inventive concept addresses these limitations by introducing rounded corner shapes, tapered walls, and recessed areas, ensuring improved product safety and user experience.

The enhanced blister pack comprises a bottom film with at least one blister pocket, featuring a rounded corner shape to reduce the risk of sharp edges. The blister pocket can also have a tapered wall shape, allowing for easier removal of the medicinal product. Additionally, a recessed area shape can be incorporated to increase storage capacity. A lidding film is sealed to the bottom film, and a strip of active material with a release function can be incorporated into the blister pocket for controlled release of medicinal substances over a predetermined period. The blister pack can be produced using a high-speed system, comprising a tool for forming the bottom film, a lidding film applicator, and a strip applicator.

The new inventive concept introduces novel shapes and designs for the blister pocket, such as rounded corners, tapered walls, and recessed areas, which provide improved product safety and user experience. The incorporation of a strip of active material with a release function enables controlled release of medicinal substances, which is not present in the original patent. These features represent a non-obvious improvement over the original design.

Alternative embodiments of the inventive concept could include different shapes and sizes of the blister pocket, varying materials for the bottom film and lidding film, and different types of active materials with release functions. Additionally, the system for producing blister packs could be modified to accommodate different production speeds and capacities.

The enhanced blister pack design has significant commercial potential in the pharmaceutical industry, particularly for medicinal products requiring controlled release. The improved safety and efficiency features also make it attractive for use in hospitals and healthcare facilities. The high-speed production system could be marketed to pharmaceutical companies and contract manufacturers, enabling them to produce blister packs at a lower cost and with increased efficiency.